123 related articles for article (PubMed ID: 11990391)
1. Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
Börjesson A; Wang X; Sun Z; Inghammar M; Truedsson L; Andersson R
Dig Liver Dis; 2002 Mar; 34(3):190-6. PubMed ID: 11990391
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats.
Sun Z; Wang X; Deng X; Lasson A; Soltesz V; Börjesson A; Andersson R
Dig Surg; 2000; 17(1):57-65. PubMed ID: 10720833
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion.
Sun Z; Wang X; Lasson A; Böjesson A; Annborn M; Andersson R
Scand J Gastroenterol; 2001 Jan; 36(1):55-65. PubMed ID: 11218240
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1.
Sun Z; Olanders K; Lasson A; Dib M; Annborn M; Andersson K; Wang X; Andersson R
J Surg Res; 2002 Jun; 105(2):220-33. PubMed ID: 12121711
[TBL] [Abstract][Full Text] [Related]
5. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
Leveau P; Wang X; Sun Z; Börjesson A; Andersson E; Andersson R
Biochem Pharmacol; 2005 May; 69(9):1325-31. PubMed ID: 15826603
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats.
Olanders K; Börjesson A; Sun ZW; Andersson R
Scand J Gastroenterol; 2003 Jun; 38(6):618-25. PubMed ID: 12825870
[TBL] [Abstract][Full Text] [Related]
7. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats.
Andersson R; Wang X; Sun Z; Deng X; Soltesz V; Ihse I
Pancreas; 1998 Aug; 17(2):107-19. PubMed ID: 9700940
[TBL] [Abstract][Full Text] [Related]
8. Effects of molsidomine and lexipafant in hepatic ischaemia--reperfusion injury.
Aldemir M; Boşnak M; Al B; Büyükbayram H; Taçyildiz I
Injury; 2004 Mar; 35(3):232-7. PubMed ID: 15124788
[TBL] [Abstract][Full Text] [Related]
9. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis.
Wang X; Sun Z; Börjesson A; Haraldsen P; Aldman M; Deng X; Leveau P; Andersson R
Int J Pancreatol; 1999 Feb; 25(1):45-52. PubMed ID: 10211421
[TBL] [Abstract][Full Text] [Related]
10. Roles of platelet-activating factor, interleukin-1beta and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion.
Sun Z; Wang X; Lasson A; Börjesson A; Leveau P; Haraldsen P; Andersson R
J Surg Res; 1999 Nov; 87(1):90-100. PubMed ID: 10527709
[TBL] [Abstract][Full Text] [Related]
11. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.
Johnson CD; Kingsnorth AN; Imrie CW; McMahon MJ; Neoptolemos JP; McKay C; Toh SK; Skaife P; Leeder PC; Wilson P; Larvin M; Curtis LD
Gut; 2001 Jan; 48(1):62-9. PubMed ID: 11115824
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction.
Wang X; Sun Z; Börjesson A; Andersson R
Br J Surg; 1999 Mar; 86(3):411-6. PubMed ID: 10201790
[TBL] [Abstract][Full Text] [Related]
13. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis.
Lane JS; Todd KE; Gloor B; Chandler CF; Kau AW; Ashley SW; Reber HA; McFadden DW
J Surg Res; 2001 Aug; 99(2):365-70. PubMed ID: 11469912
[TBL] [Abstract][Full Text] [Related]
14. Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats.
Rivera JA; Werner J; Warshaw AL; Lewandrowski KB; Rattner DW; Fernández del Castillo C
Int J Pancreatol; 1998 Apr; 23(2):101-6. PubMed ID: 9629507
[TBL] [Abstract][Full Text] [Related]
15. Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation.
Taggart DP
Ann Thorac Surg; 2001 Jan; 71(1):238-42. PubMed ID: 11216754
[TBL] [Abstract][Full Text] [Related]
16. Lexipafant inhibits platelet activating factor enhanced neutrophil functions.
Schwartz JD; Shamamian P; Grossi EA; Schwartz DS; Marcus SG; Steiner F; Jacobs CE; Tayyarah M; Eng K; Colvin SB; Galloway AC
J Surg Res; 1997 May; 69(2):240-8. PubMed ID: 9224389
[TBL] [Abstract][Full Text] [Related]
17. Effects of anticoagulant treatment on intestinal ischaemia and reperfusion injury in rats.
Olanders K; Börjesson A; Zhao X; Andersson R
Acta Anaesthesiol Scand; 2005 Apr; 49(4):517-24. PubMed ID: 15777300
[TBL] [Abstract][Full Text] [Related]
18. Lexipafant in severe acute pancreatitis: the final word?
Ulrich CD
Curr Gastroenterol Rep; 2001 Apr; 3(2):85-7. PubMed ID: 11276374
[No Abstract] [Full Text] [Related]
19. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.
Schifitto G; Sacktor N; Marder K; McDermott MP; McArthur JC; Kieburtz K; Small S; Epstein LG
Neurology; 1999 Jul; 53(2):391-6. PubMed ID: 10430432
[TBL] [Abstract][Full Text] [Related]
20. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.
Souza DG; Pinho V; Soares AC; Shimizu T; Ishii S; Teixeira MM
Br J Pharmacol; 2003 Jun; 139(4):733-40. PubMed ID: 12812996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
